##fileformat=VCFv4.1
##VEP="v110" time="2023-12-03 21:14:57" cache="/net/isilonP/public/ro/ensweb-data/latest/tools/www/e110/vep/cache/homo_sapiens/110_GRCh38" db="homo_sapiens_core_110_38@hh-mysql-ens-species-web-1" 1000genomes="phase3" COSMIC="97" ClinVar="202301" HGMD-PUBLIC="20204" assembly="GRCh38.p14" dbSNP="154" gencode="GENCODE 44" genebuild="2014-07" gnomADe="r2.1.1" gnomADg="v3.1.2" polyphen="2.2.3" regbuild="1.0" sift="6.2.1"
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Allele|Consequence|IMPACT|SYMBOL|Gene|Feature_type|Feature|BIOTYPE|EXON|INTRON|HGVSc|HGVSp|cDNA_position|CDS_position|Protein_position|Amino_acids|Codons|Existing_variation|DISTANCE|STRAND|FLAGS|SYMBOL_SOURCE|HGNC_ID|MANE_SELECT|MANE_PLUS_CLINICAL|TSL|APPRIS|CCDS|ENSP|SWISSPROT|TREMBL|UNIPARC|UNIPROT_ISOFORM|SIFT|PolyPhen|HGVS_OFFSET|AF|AFR_AF|AMR_AF|EAS_AF|EUR_AF|SAS_AF|gnomADe_AF|gnomADe_AFR_AF|gnomADe_AMR_AF|gnomADe_ASJ_AF|gnomADe_EAS_AF|gnomADe_FIN_AF|gnomADe_NFE_AF|gnomADe_OTH_AF|gnomADe_SAS_AF|gnomADg_AF|gnomADg_AFR_AF|gnomADg_AMI_AF|gnomADg_AMR_AF|gnomADg_ASJ_AF|gnomADg_EAS_AF|gnomADg_FIN_AF|gnomADg_MID_AF|gnomADg_NFE_AF|gnomADg_OTH_AF|gnomADg_SAS_AF|FREQS|CLIN_SIG|SOMATIC|PHENO|PUBMED|Mastermind_MMID3|DisGeNET|CADD_PHRED|CADD_RAW|MaxEntScan_alt|MaxEntScan_diff|MaxEntScan_ref|ada_score|rf_score|BLOSUM62|Geno2MP_HPO_count|Geno2MP_URL|GO|EVE_CLASS|EVE_SCORE|PHENOTYPES|AA|LOEUF">
##Mastermind_MMID3=Mastermind MMID3 variant identifier(s), as gene:key. Link to the Genomenon Mastermind Genomic Search Engine.
##DisGeNET=Variant-Disease-PMID associations from the DisGeNET database. The output includes the PMID of the publication reporting the Variant-Disease association, DisGeNET score for the Variant-Disease association, name of associated disease. Each value is separated by ':'
##CADD_PHRED=PHRED-like scaled CADD score. CADD is only available here for non-commercial use. See CADD website for more information.
##CADD_RAW=Raw CADD score. CADD is only available here for non-commercial use. See CADD website for more information.
##MaxEntScan_alt=MaxEntScan alternate sequence score
##MaxEntScan_diff=MaxEntScan score difference
##MaxEntScan_ref=MaxEntScan reference sequence score
##ada_score=dbscSNV ADA score
##rf_score=dbscSNV RF score
##BLOSUM62=BLOSUM62 substitution score for the reference and alternative amino acids
##Geno2MP_HPO_count=Number of phenotypic profiles in Geno2MP
##Geno2MP_URL=Link to Geno2MP variant page
##GO=GO terms associated with transcript or protein product
##EVE_CLASS=Classification (Benign, Uncertain, or Pathogenic) when setting 75% as uncertain
##EVE_SCORE=Score from EVE model
##PHENOTYPES=Phenotypes associated with overlapping genomic features
##AA=Ancestral allele from /net/isilonP/public/ro/ensweb-data/latest/tools/www/e110/vep/plugin_data/homo_sapiens_ancestor_GRCh38_109.fa.gz
##LOEUF=Loss-of-function observed/expected upper bound fraction
##VEP-command-line='vep --af --af_1kg --af_gnomade --af_gnomadg --appris --biotype --cache --ccds --check_existing --coding_only --database 0 --dir [PATH]/cache --dir_plugins [PATH]/VEP_plugins --distance 5000 --fasta_dir [PATH]/fasta --filter_common --force --fork 4 --hgvs --input_file [PATH]/input.txt --mane --output_file [PATH]/output.vcf --plugin [PATH]/loeuf_dataset_grch38.tsv.gz,match_by=gene --polyphen b --protein --pubmed --quiet --safe --sift b --stats_text --symbol --transcript_version --tsl --uniprot --vcf'
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
13	32340140	chr13:g.32340140_32340142delATTinsGTA	ATT	GTA	.	.	CSQ=GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTA|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTA|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTA|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTA|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTA|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTA|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTA|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTA|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTA|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTA|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
13	32340140	chr13:g.32340140_32340142delATTinsGTA	ATT	GTA	.	.	CSQ=GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTA|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTA|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTA|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTA|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTA|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTA|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTA|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTA|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTA|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTA|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTA|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTA|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
13	32340140	chr13:g.32340140_32340142delATTinsGTC	ATT	GTC	.	.	CSQ=GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTC|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTC|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTC|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTC|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTC|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTC|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTC|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTC|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTC|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTC|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
13	32340140	chr13:g.32340140_32340142delATTinsGTC	ATT	GTC	.	.	CSQ=GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTC|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTC|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTC|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTC|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTC|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTC|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTC|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTC|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTC|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTC|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTC|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTC|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
13	32340140	chr13:g.32340140_32340142delATTinsGTG	ATT	GTG	.	.	CSQ=GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTG|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTG|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTG|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTG|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTG|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTG|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTG|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTG|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTG|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTG|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
13	32340140	chr13:g.32340140_32340142delATTinsGTG	ATT	GTG	.	.	CSQ=GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000380152.8|protein_coding|11/27||ENST00000380152.8:c.5785_5787delinsGTG|ENSP00000369497.3:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|NM_000059.4||5|P2|CCDS9344.1|ENSP00000369497|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000722:telomere_maintenance_via_recombination&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0001556:oocyte_maturation&GO:0001833:inner_cell_mass_cell_proliferation&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005694:chromosome&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0006978:DNA_damage_response_-_signal_transduction_by_p53_class_mediator_resulting_in_transcription_of_p21_class_mediator&GO:0007049:cell_cycle&GO:0007141:male_meiosis_I&GO:0007283:spermatogenesis&GO:0007420:brain_development&GO:0008283:cell_population_proliferation&GO:0008585:female_gonad_development&GO:0008630:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage&GO:0010165:response_to_X-ray&GO:0010225:response_to_UV-C&GO:0010332:response_to_gamma_radiation&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030097:hemopoiesis&GO:0030141:secretory_granule&GO:0031297:replication_fork_processing&GO:0032465:regulation_of_cytokinesis&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042771:intrinsic_apoptotic_signaling_pathway_in_response_to_DNA_damage_by_p53_class_mediator&GO:0042802:identical_protein_binding&GO:0043009:chordate_embryonic_development&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0045931:positive_regulation_of_mitotic_cell_cycle&GO:0050896:response_to_stimulus&GO:0051276:chromosome_organization&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071425:hematopoietic_stem_cell_proliferation&GO:0071479:cellular_response_to_ionizing_radiation&GO:0072089:stem_cell_proliferation&GO:0090398:cellular_senescence&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000470094.2|nonsense_mediated_decay|11/28||ENST00000470094.2:c.5785_5787delinsGTG|ENSP00000434898.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||5|||ENSP00000434898||H0YE37.44|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000528762.2|nonsense_mediated_decay|11/28||ENST00000528762.2:c.5785_5787delinsGTG|ENSP00000433168.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||4|||ENSP00000433168||H0YD86.53|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000530893.7|protein_coding|11/27||ENST00000530893.7:c.5416_5418delinsGTG|ENSP00000499438.2:p.Ile1806Val|5983-5985|5416-5418|1806|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||1|A2||ENSP00000499438||A0A590UJI7.10||||||||||||||||||||||||||||||||||||||10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000544455.6|protein_coding|11/27||ENST00000544455.6:c.5785_5787delinsGTG|ENSP00000439902.1:p.Ile1929Val|5884-5886|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||1|P2|CCDS9344.1|ENSP00000439902|P51587.235||UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000614259.2|nonsense_mediated_decay|10/26||ENST00000614259.2:c.5785_5787delinsGTG|ENSP00000506251.1:p.Ile1929Val|5785-5787|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101|||2|||ENSP00000506251||A0A7P0TAP7.6|UPI00194D3080||tolerated(0.26)|benign(0.093)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0050896:response_to_stimulus|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000665585.2|nonsense_mediated_decay|11/29||ENST00000665585.2:c.5785_5787delinsGTG|ENSP00000499570.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||||ENSP00000499570||A0A590UJU6.11|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant&NMD_transcript_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000666593.2|nonsense_mediated_decay|11/26||ENST00000666593.2:c.5785_5787delinsGTG|ENSP00000499256.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||||ENSP00000499256||A0A590UJ24.9|||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0006281:DNA_repair|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000680887.1|protein_coding|11/27||ENST00000680887.1:c.5785_5787delinsGTG|ENSP00000505508.1:p.Ile1929Val|5910-5912|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||P2|CCDS9344.1|ENSP00000505508|P51587.235|A0A7P0T9D7.6|UPI00001FCBCC||tolerated(0.32)|benign(0.037)|||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000152:nuclear_ubiquitin_ligase_complex&GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0000781:chromosome_-_telomeric_region&GO:0000800:lateral_element&GO:0002020:protease_binding&GO:0003677:DNA_binding&GO:0003697:single-stranded_DNA_binding&GO:0005515:protein_binding&GO:0005634:nucleus&GO:0005654:nucleoplasm&GO:0005737:cytoplasm&GO:0005813:centrosome&GO:0005815:microtubule_organizing_center&GO:0005829:cytosol&GO:0005856:cytoskeleton&GO:0006281:DNA_repair&GO:0006289:nucleotide-excision_repair&GO:0006302:double-strand_break_repair&GO:0006310:DNA_recombination&GO:0006338:chromatin_remodeling&GO:0006355:regulation_of_DNA-templated_transcription&GO:0006974:cellular_response_to_DNA_damage_stimulus&GO:0007049:cell_cycle&GO:0010484:H3_histone_acetyltransferase_activity&GO:0010485:H4_histone_acetyltransferase_activity&GO:0030141:secretory_granule&GO:0032991:protein-containing_complex&GO:0033593:BRCA2-MAGE-D1_complex&GO:0033600:negative_regulation_of_mammary_gland_epithelial_cell_proliferation&GO:0035518:histone_H2A_monoubiquitination&GO:0042802:identical_protein_binding&GO:0043015:gamma-tubulin_binding&GO:0045893:positive_regulation_of_DNA-templated_transcription&GO:0050896:response_to_stimulus&GO:0051298:centrosome_duplication&GO:0051865:protein_autoubiquitination&GO:0070200:establishment_of_protein_localization_to_telomere&GO:0071479:cellular_response_to_ionizing_radiation&GO:1990391:DNA_repair_complex&GO:1990426:mitotic_recombination-dependent_replication_fork_processing&GO:2000001:regulation_of_DNA_damage_checkpoint|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01,GTG|missense_variant|MODERATE|BRCA2|ENSG00000139618|Transcript|ENST00000700202.2|protein_coding|11/27||ENST00000700202.2:c.5785_5787delinsGTG|ENSP00000514856.2:p.Ile1929Val|5984-5986|5785-5787|1929|I/V|ATT/GTG|||1||HGNC|HGNC:1101||||A2||ENSP00000514856||A0A8V8TPZ2.1|UPI00201AF897||||||||||||||||||||||||||||||||||||BRCA2:I1929V|10399947:0.70:Malignant_neoplasm_of_breast&10978364:0.70:Malignant_neoplasm_of_breast&11139248:0.70:Malignant_neoplasm_of_breast&11149425:0.70:Malignant_neoplasm_of_breast&11241844:0.70:Malignant_neoplasm_of_breast&11948477:0.70:Malignant_neoplasm_of_breast&12145750:0.70:Malignant_neoplasm_of_breast&12373604:0.70:Malignant_neoplasm_of_breast&12442274:0.70:Malignant_neoplasm_of_breast&12569143:0.70:Malignant_neoplasm_of_breast&12938098:0.70:Malignant_neoplasm_of_breast&14722926:0.70:Malignant_neoplasm_of_breast&15026808:0.70:Malignant_neoplasm_of_breast&15172753:0.70:Malignant_neoplasm_of_breast&15365993:0.70:Malignant_neoplasm_of_breast&16793542:0.70:Malignant_neoplasm_of_breast&9150152:0.70:Malignant_neoplasm_of_breast&9609997:0.70:Malignant_neoplasm_of_breast&9654203:0.70:Malignant_neoplasm_of_breast&9971877:0.70:Malignant_neoplasm_of_breast&:0.70:BREAST-OVARIAN_CANCER_FAMILIAL_SUSCEPTIBILITY_TO_2||||||||3|||GO:0000724:double-strand_break_repair_via_homologous_recombination&GO:0003677:DNA_binding&GO:0006281:DNA_repair&GO:0006310:DNA_recombination|||BRCA2_associated_CANCER+G2P+ENSG00000139618&FANCONI_ANEMIA_COMPLEMENTATION_GROUP_D_TYPE_1+G2P+ENSG00000139618&Breast_Cancer+MIM_morbid+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&FANCONI_ANEMIA__COMPLEMENTATION_GROUP_D1+MIM_morbid+ENSG00000139618&GLIOMA_SUSCEPTIBILITY_3+MIM_morbid+ENSG00000139618&Medulloblastoma+MIM_morbid+ENSG00000139618&PANCREATIC_CANCER__SUSCEPTIBILITY_TO__2+MIM_morbid+ENSG00000139618&Prostate_Cancer+MIM_morbid+ENSG00000139618&WILMS_TUMOR_1+MIM_morbid+ENSG00000139618&Cholangiocarcinoma+Orphanet+ENSG00000139618&Familial_pancreatic_carcinoma+Orphanet+ENSG00000139618&Familial_prostate_cancer+Orphanet+ENSG00000139618&Fanconi_anemia+Orphanet+ENSG00000139618&Hereditary_breast_and_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Hereditary_breast_cancer+Orphanet+ENSG00000139618&Hereditary_site-specific_ovarian_cancer_syndrome+Orphanet+ENSG00000139618&Inherited_cancer-predisposing_syndrome_due_to_biallelic_BRCA2_mutations+Orphanet+ENSG00000139618&Nephroblastoma+Orphanet+ENSG00000139618&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs79538375&ClinVar:_phenotype_not_specified+ClinVar+rs79538375&Familial_cancer_of_breast+ClinVar+rs79538375&Fanconi_anemia_complementation_group_D1+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs79538375&Hereditary_cancer-predisposing_syndrome+ClinVar+rs79538375&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs1555284396&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs397507806&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs397507806&BREAST-OVARIAN_CANCER__FAMILIAL__SUSCEPTIBILITY_TO__2+ClinVar+rs765881070&Hereditary_breast_ovarian_cancer_syndrome+ClinVar+rs765881070&Hereditary_cancer-predisposing_syndrome+ClinVar+rs765881070|ATT|6.3400e-01
